Word

BI BIOLOGICAL INDUSTRIES

Status

Registered

Status Code

700

Status Date

Tuesday, April 10, 2018

Serial Number

87452085

Registration Number

5442098

Registration Date

Tuesday, April 10, 2018

Mark Type

4000

Filing Date

Tuesday, May 16, 2017

Published for Opposition

Tuesday, January 23, 2018

Trademark Owner History

Biological Industries Israel Beit Haemek Ltd. - Original Registrant

Classifications

41 Education services, namely, conducting programs and courses in the field of science and medicine; publication services, namely, publishing of journals, books and handbooks; publication of scientific research, namely, publishing and issuing scientific papers in relation to medical technology; Publication of the results of clinical trials for pharmaceutical preparations; Arranging and conducting educational conferences, courses, trainings, seminars in the field of science and medicine

5 Medical and veterinary preparations and articles, namely, bacterial and bacteriological preparations for medical or veterinary purposes; Diagnostic preparations for medical and veterinary use; Diagnostic preparations for medical or veterinary purposes, Diagnostic agents, preparations and substances for medical purposes; Pharmaceuticals and natural remedies, namely, natural remedy preparations for the treatment of gastro-intestinal conditions, hormonal and chemical imbalances, and sleep disorders; Bacteriological culture mediums; serums, namely, medicated hair serums; Pharmaceutical preparations, namely, medicated hair serums; Pharmaceutical preparations for human use, namely, human vaccine preparations; Pharmaceutical preparations for medical purposes, namely, diagnostic preparations for medical purposes; Pharmaceutical preparations for activating cellular function; Cellular function activating agents for medical purposes; Cellulose esters for pharmaceutical purposes; Medicines for intestinal disorders; Pharmaceutical drugs, namely, drug delivery agents in the form of powders, tablets and capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drugs for medical purposes, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Live organs and tissues for surgical purpose; Stem cells for medical purposes; Clinical medical reagents; Cultures of microorganism for medical use; Medical products to support the growth of stem cells, namely, cytostatics for pharmaceutical purposes; Surgical implants grown from stem cells in the nature of surgical implants comprised of living tissues; Medical diagnostic reagents; Reargents for blood grouping in the nature of reagents for medical use; Blood components, namely, platelet rich blood plasma and stem cells for medical use; Blood plasma; Blood substitutes for human use

1 Chemicals used in industry and science; Mixtures of chemicals and microorganisms for sterilizing compost for use in agriculture; Chemical substances, chemical materials and chemical preparations and natural elements all the foregoing being chemicals for use in industry and science; Reagents for scientific or medical research use; Reagents for scientific or medical research use, namely, reagents for use in immunoserology; Diagnostic preparations other than for medical or veterinary purposes; Stem cells for research and scientific purposes; Anti-freezing preparations; Freezing agents for use in freezing biological specimens, namely, cryogenic preparations in solid, liquid or gas state for use in chilling and freezing; Reagents for research purposes, namely, blood grouping reagents other than for medical use; Cell culture media for scientific and research use; Cell culture media for scientific and research use, namely, blood cell culture media for scientific use; biological activators for plants; Pharmaceuticals, medical and veterinary preparations, namely, biological preparation for use in cell cultures other than for medical or veterinary use

42 Scientific and technological services, namely, scientific research and analysis in the field of medicine; research and development services in connection with medicine; Industrial analysis and research services in the field of medicine; scientific and biological services, namely, biological cloning services; natural science services, namely, consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; medical laboratory services; medical and pharmacological research and development services; biological analysis; biological research; clinical research and medical research, namely, basic and clinical research in the field of respiratory science and medicine; biological development, namely, custom design and development of safe chemical and biological agent simulants for use in air quality measurement; Consultancy relating to pharmaceutical research and development, namely, technical consulting in the field of pharmaceutical studies; Research in the field of stem cells; Research and development of vaccines and medicines; Development of pharmaceutical preparations and medicines; Analysis of human serum for medical research; Pharmaceutical drug development services; Provision of information and data relating to medical and veterinary research and development; Testing, authentication and quality control for others in the field of medical and pharmaceutical research; Advisory services relating to material testing, namely, materials testing and analysing; Analysis of human tissues for medical research; Scientific research and development services relating to the isolation and cultivation of human tissues and cells

"BIOLOGICAL INDUSTRIES"

Trademark Events

Apr 8, 2024

Teas Section 8 & 15 Received

Apr 10, 2023

Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed

Apr 10, 2018

Registered-Principal Register

Jan 23, 2018

Official Gazette Publication Confirmation E-Mailed

Jan 23, 2018

Published For Opposition

Jan 3, 2018

Notification Of Notice Of Publication E-Mailed

Dec 15, 2017

Electronic Record Review Complete

Dec 8, 2017

On Hold - Electronic Record Review Required

Dec 3, 2017

Assigned To Lie

Nov 22, 2017

Approved For Pub - Principal Register

Nov 21, 2017

Teas/Email Correspondence Entered

Nov 20, 2017

Correspondence Received In Law Office

Nov 20, 2017

Teas Response To Office Action Received

Aug 7, 2017

Notification Of Non-Final Action E-Mailed

Aug 7, 2017

Non-Final Action E-Mailed

Aug 7, 2017

Non-Final Action Written

Aug 7, 2017

Assigned To Examiner

May 22, 2017

New Application Office Supplied Data Entered

May 19, 2017

New Application Entered